News
Supplement combo buffers against PD neurodegeneration in rodent model
NEW YORK – The combination of four nutritional supplements restored some neurotransmitter levels to near normal.
News
Sensory feedback modalities tackle gait, balance problems in PD
NEW YORK – Pilot studies of a standardized stimulation technique show promising clinical results backed by fMRI...
News
MS cognitive decline buffered by early high vitamin D levels
BERLIN – Smokers took a “clinically significant” cognitive hit, however.
News
Low spinal cord volume linked to higher MS disability
BERLIN – Spinal cord volume tracked with disability level in patients with a mismatch between disability status and intracerebral lesion load.
News
No elevated cancer risk with MS therapies in COMBAT-MS data
BERLIN – No elevations were seen in overall cancer rates, or in breast cancer rates.
News
No signal for CV, breast effects with bioidentical vaginal estrogen for dyspareunia
Low-dose vaginal softgel is approved for treating moderate to severe dyspareunia associated with menopause.
News
With more mindfulness, menopausal symptoms wane
Women in midlife with the most stress had the most benefit from mindfulness.
News
For dyspareunia, intravaginal prasterone may work best soon after menopause
Age and previous hormone replacement therapy did not influence prasterone’s efficacy in treating dyspareunia.
News
For solitary renal tumors, RFA looks good at 10 years
The recurrence rate following radiofrequency ablation of small renal tumors was low, with no new tumors after 5 years.
News
DEA moves Epidiolex to schedule V, clearing the way for marketing
The cannabis-derived drug to treat pediatric seizures should be available within 6 weeks.
News
Opioids don’t treat pain better than ibuprofen after venous ablation surgery
Those who took ibuprofen to control postsurgical pain fared just as well.
News
NHLBI commits to a sickle cell cure
A “circle of partners” seeks to bring best practices to all corners of the world while pushing for a cure.
News
UN aims to eradicate TB by 2030
A concerted a lethal disease affecting one-...